Phase II Exploratory Clinical Study of KUX-1151
Phase of Trial: Phase II
Latest Information Update: 24 Oct 2015
Price : $35 *
At a glance
- Drugs KUX 1151 (Primary)
- Indications Gout; Hyperuricaemia
- Focus Therapeutic Use
- Sponsors Kissei Pharmaceutical
- 31 Aug 2018 Biomarkers information updated
- 16 Oct 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 19 Apr 2015 Status changed from recruiting to active, no longer recruiting as per ClinicalTrials.gov record.